As UK deal activity got off to a strong start in 2022, market reports show that general M&A and corporate transactions remain resilient despite global events. We have been kept busy and the mid-market has seen no shortage of transactional activity, though certain sectors are clearly more buoyant than others.
Buyer appetite continues to show confidence in the market, and we have seen strong levels of private equity investment and M&A activity across all our specialist sectors.
Some of our latest deals:
Advised the sellers on the disposal of their shares in LTE Scientific Limited (manufacturer of laboratory equipment) to SDI Group Plc.
Advised on the sale of Pharmaspectra Group by Private Equity firm Inflexion to a listed buyer in a multi-million pound deal.
Sale of London-headquartered global executive search firm, TritonExec to the talent solutions division of Singaporean based Prytek.
Sale of care provider CareConcepts (Appleton) Ltd by CareConcepts (BVI) to marion 1 Ltd.
Advised four individual sellers on the sale of their shares in 4D Data Centres Limited to UK managed services provider Redcentric.
Majority shareholder sale to pet care company Dayes.
Private equity funded acquisition of ABS Precision Ltd.
Sale of a UK headquartered international recruitment business to an overseas acquirer.
Advised leading care home investor Octopus Real Estate on a £100m acquisition and funding deal with the Hamberley Group.
Share purchase of Ermin Plant (Hire & Services) Ltd.
Purchase of the entire issued share capital of G M Packaging (UK) Limited.
Sale of property SPV holding the freehold of ASDA in Halesowen.
Sale of child personal care brand, Childs Farm to consumer goods business PZ Cussons.
Private Equity investment by LDC in Bristol- based artisan cake manufacturer and supplier Cakesmiths.
Advised on the purchase by a drinks company of the remaining share capital of a distillery and drinks manufacturer from the original founder shareholders.
Investment by Foresight in Homelink Healthcare and a subsequent rights issue to raise a further £500,000 from its existing shareholders.
Purchase of the entire issued share capital of Rumbol Products Limited, a family manufacturing business based in Clydebank, Scotland.
Acquisition of various oral pharmaceutical products from the Essential Holdings Group.
Sale of 5 star London hotel to European investment company.